Global Generic Drugs Competitive Landscape Professional Research Report 2024

Research Summary

Generic drugs are pharmaceutical products that are bioequivalent to brand-name drugs in terms of active ingredients, dosage form, strength, route of administration, and intended use. These drugs are marketed after the patent protection of the original innovator drug has expired. Generic drugs offer the same therapeutic effects, safety, and quality as their brand-name counterparts but are typically available at a lower cost. The production of generic drugs involves demonstrating bioequivalence through rigorous testing, ensuring that the generic version performs similarly to the innovator drug in terms of absorption and efficacy. Generic drugs play a crucial role in providing affordable alternatives to brand-name medications, contributing to cost savings for patients, healthcare systems, and insurers. They undergo regulatory approval processes to ensure their safety and efficacy, making them a widely accepted and accessible option for various medical conditions.

According to DIResearch's in-depth investigation and research, the global Generic Drugs market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Generic Drugs include Teva, Novartis - Sandoz, Mylan, Sun Pharmaceutical, Aspen, Fresenius Kabi, Pfizer (Hospira), Sanofi, Aurobindo, Lupin, Dr. Reddy's, Apotex, Cipla, ENDO (Par Pharmaceutical), Stada Arzneimittel, Krka Group, Valeant, Nichi-Iko Pharmaceutical, Zydus Cadila, Hikma, Hovid Berhad, Pharmaniaga Berhad, Duopharma Biotech, Kotra Pharma, HOE Pharmaceutical, Y.S.P. Industries etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Generic Drugs. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Generic Drugs market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Generic Drugs market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Generic Drugs industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Generic Drugs Include:

Teva

Novartis - Sandoz

Mylan

Sun Pharmaceutical

Aspen

Fresenius Kabi

Pfizer (Hospira)

Sanofi

Aurobindo

Lupin

Dr. Reddy's

Apotex

Cipla

ENDO (Par Pharmaceutical)

Stada Arzneimittel

Krka Group

Valeant

Nichi-Iko Pharmaceutical

Zydus Cadila

Hikma

Hovid Berhad

Pharmaniaga Berhad

Duopharma Biotech

Kotra Pharma

HOE Pharmaceutical

Y.S.P. Industries

Generic Drugs Product Segment Include:

Prescription

Non-Prescription Drugs

Generic Drugs Product Application Include:

Hospital

Clinic

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Generic Drugs Industry PESTEL Analysis

Chapter 3: Global Generic Drugs Industry Porter's Five Forces Analysis

Chapter 4: Global Generic Drugs Major Regional Market Size and Forecast Analysis

Chapter 5: Global Generic Drugs Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Generic Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Generic Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Generic Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Generic Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Generic Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Generic Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Generic Drugs Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Generic Drugs Market Overview

1.1 Product Definition and Statistical Scope

1.2 Generic Drugs Product by Type

1.2.1 Global Generic Drugs Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Prescription

1.2.3 Non-Prescription Drugs

1.3 Generic Drugs Product by Application

1.3.1 Global Generic Drugs Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global Generic Drugs Market Revenue Analysis (2019-2030)

1.5 Generic Drugs Market Development Status and Trends

1.5.1 Generic Drugs Industry Development Status Analysis

1.5.2 Generic Drugs Industry Development Trends Analysis

2 Generic Drugs Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Generic Drugs Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Generic Drugs Market Analysis by Regions

4.1 Generic Drugs Overall Market: 2023 VS 2024 VS 2030

4.2 Global Generic Drugs Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Generic Drugs Revenue and Market Share by Region (2019-2024)

4.2.2 Global Generic Drugs Revenue Forecast by Region (2025-2030)

5 Global Generic Drugs Market Size by Type and Application

5.1 Global Generic Drugs Market Size by Type

5.2 Global Generic Drugs Market Size by Application

6 North America

6.1 North America Generic Drugs Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Generic Drugs Market Size by Type

6.4 North America Generic Drugs Market Size by Application

6.5 North America Generic Drugs Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Generic Drugs Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Generic Drugs Market Size by Type

7.4 Europe Generic Drugs Market Size by Application

7.5 Europe Generic Drugs Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Generic Drugs Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Generic Drugs Market Size by Type

8.4 China Generic Drugs Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Generic Drugs Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Generic Drugs Market Size by Type

9.4 APAC (excl. China) Generic Drugs Market Size by Application

9.5 APAC (excl. China) Generic Drugs Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Generic Drugs Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Generic Drugs Market Size by Type

10.4 Latin America Generic Drugs Market Size by Application

10.5 Latin America Generic Drugs Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Generic Drugs Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Generic Drugs Market Size by Type

11.4 Middle East & Africa Generic Drugs Market Size by Application

11.5 Middle East & Africa Generic Drugs Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Generic Drugs Market Revenue by Key Manufacturers (2020-2024)

12.2 Generic Drugs Competitive Landscape Analysis and Market Dynamic

12.2.1 Generic Drugs Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Teva

13.1.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Teva Generic Drugs Product Portfolio

13.1.3 Teva Generic Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Novartis - Sandoz

13.2.1 Novartis - Sandoz Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Novartis - Sandoz Generic Drugs Product Portfolio

13.2.3 Novartis - Sandoz Generic Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 Mylan

13.3.1 Mylan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Mylan Generic Drugs Product Portfolio

13.3.3 Mylan Generic Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Sun Pharmaceutical

13.4.1 Sun Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Sun Pharmaceutical Generic Drugs Product Portfolio

13.4.3 Sun Pharmaceutical Generic Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Aspen

13.5.1 Aspen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Aspen Generic Drugs Product Portfolio

13.5.3 Aspen Generic Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 Fresenius Kabi

13.6.1 Fresenius Kabi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Fresenius Kabi Generic Drugs Product Portfolio

13.6.3 Fresenius Kabi Generic Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Pfizer (Hospira)

13.7.1 Pfizer (Hospira) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Pfizer (Hospira) Generic Drugs Product Portfolio

13.7.3 Pfizer (Hospira) Generic Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 Sanofi

13.8.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Sanofi Generic Drugs Product Portfolio

13.8.3 Sanofi Generic Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 Aurobindo

13.9.1 Aurobindo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Aurobindo Generic Drugs Product Portfolio

13.9.3 Aurobindo Generic Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Lupin

13.10.1 Lupin Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Lupin Generic Drugs Product Portfolio

13.10.3 Lupin Generic Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 Dr. Reddy's

13.11.1 Dr. Reddy's Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 Dr. Reddy's Generic Drugs Product Portfolio

13.11.3 Dr. Reddy's Generic Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.12 Apotex

13.12.1 Apotex Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 Apotex Generic Drugs Product Portfolio

13.12.3 Apotex Generic Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.13 Cipla

13.13.1 Cipla Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.13.2 Cipla Generic Drugs Product Portfolio

13.13.3 Cipla Generic Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.14 ENDO (Par Pharmaceutical)

13.14.1 ENDO (Par Pharmaceutical) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.14.2 ENDO (Par Pharmaceutical) Generic Drugs Product Portfolio

13.14.3 ENDO (Par Pharmaceutical) Generic Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.15 Stada Arzneimittel

13.15.1 Stada Arzneimittel Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.15.2 Stada Arzneimittel Generic Drugs Product Portfolio

13.15.3 Stada Arzneimittel Generic Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.16 Krka Group

13.16.1 Krka Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.16.2 Krka Group Generic Drugs Product Portfolio

13.16.3 Krka Group Generic Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.17 Valeant

13.17.1 Valeant Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.17.2 Valeant Generic Drugs Product Portfolio

13.17.3 Valeant Generic Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.18 Nichi-Iko Pharmaceutical

13.18.1 Nichi-Iko Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.18.2 Nichi-Iko Pharmaceutical Generic Drugs Product Portfolio

13.18.3 Nichi-Iko Pharmaceutical Generic Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.19 Zydus Cadila

13.19.1 Zydus Cadila Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.19.2 Zydus Cadila Generic Drugs Product Portfolio

13.19.3 Zydus Cadila Generic Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.20 Hikma

13.20.1 Hikma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.20.2 Hikma Generic Drugs Product Portfolio

13.20.3 Hikma Generic Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.21 Hovid Berhad

13.21.1 Hovid Berhad Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.21.2 Hovid Berhad Generic Drugs Product Portfolio

13.21.3 Hovid Berhad Generic Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.22 Pharmaniaga Berhad

13.22.1 Pharmaniaga Berhad Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.22.2 Pharmaniaga Berhad Generic Drugs Product Portfolio

13.22.3 Pharmaniaga Berhad Generic Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.23 Duopharma Biotech

13.23.1 Duopharma Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.23.2 Duopharma Biotech Generic Drugs Product Portfolio

13.23.3 Duopharma Biotech Generic Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.24 Kotra Pharma

13.24.1 Kotra Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.24.2 Kotra Pharma Generic Drugs Product Portfolio

13.24.3 Kotra Pharma Generic Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.25 HOE Pharmaceutical

13.25.1 HOE Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.25.2 HOE Pharmaceutical Generic Drugs Product Portfolio

13.25.3 HOE Pharmaceutical Generic Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.26 Y.S.P. Industries

13.26.1 Y.S.P. Industries Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.26.2 Y.S.P. Industries Generic Drugs Product Portfolio

13.26.3 Y.S.P. Industries Generic Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Generic Drugs Industry Chain Analysis

14.2 Generic Drugs Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Generic Drugs Typical Downstream Customers

14.4 Generic Drugs Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support